Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda.

Kaida A, Matthews LT, Kanters S, Kabakyenga J, Muzoora C, Mocello AR, Martin JN, Hunt P, Haberer J, Hogg RS, Bangsberg DR.

PLoS One. 2013 May 21;8(5):e63411. doi: 10.1371/journal.pone.0063411. Print 2013.

2.

The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study.

Shafer LA, Nsubuga RN, Chapman R, O'Brien K, Mayanja BN, White RG.

Sex Transm Infect. 2014 Aug;90(5):423-9. doi: 10.1136/sextrans-2013-051219. Epub 2014 Feb 24. Review.

3.

Equity in utilization of antiretroviral therapy for HIV-infected people in South Africa: a systematic review.

Tromp N, Michels C, Mikkelsen E, Hontelez J, Baltussen R.

Int J Equity Health. 2014 Aug 1;13:60. doi: 10.1186/s12939-014-0060-z. Review.

4.

Preconception and contraceptive care for women living with HIV.

Hoyt MJ, Storm DS, Aaron E, Anderson J.

Infect Dis Obstet Gynecol. 2012;2012:604183. doi: 10.1155/2012/604183. Epub 2012 Oct 11. Review.

5.

Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy.

Reid SD, Fidler SJ, Cooke GS.

Clin Epidemiol. 2013 Sep 26;5:387-96. doi: 10.2147/CLEP.S37069. Review.

6.

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa.

Kasirye R, Baisley K, Munderi P, Grosskurth H.

Trop Med Int Health. 2015 May;20(5):569-580. doi: 10.1111/tmi.12463. Epub 2015 Feb 6. Review.

7.

START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection.

Siedner MJ.

Open Forum Infect Dis. 2016 Feb 9;3(1):ofw032. doi: 10.1093/ofid/ofw032. eCollection 2016 Jan. Review.

Supplemental Content

Support Center